inflation, Stock and Dow Futures
Digest more
J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.
The upcoming second-quarter earnings season is expected to shift the focus of Wall Street from the ongoing trade war to the real-world impacts of corporate earnings.
Geojit Financial Services shares fell over 6% after disappointing Q1 FY26 results, with net profit dropping 37% year-over-year to ₹28.67 crore. Revenue also declined significantly, leading to concerns about the firm's financial health despite progress in its business restructuring.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.
LMT's Q2 sales are likely to have risen across all segments, but dismal earnings expectations and weak price performance raise caution.
14h
Zacks Investment Research on MSNThe Q2 Earnings Cycle Accelerates: Why Earnings Season MattersImagine that, once every few months, you must release information detailing your current financial standing. The public can see where you’ve spent money, made money, or even how much you’ve saved. Sounds intimidating,
Opening a busy week of earnings set to be dominated by big banks and tech giants like Netflix, industrial supplier Fastenal posted a solid report on Monday.
ASML Holding N.V. sees strong past performance but faces growth uncertainty amid U.S.-China trade tensions and export controls. Click for our ASML earnings update.
Investing.com - The second-quarter earnings season is likely to show the first material impact on Corporate America from an incremental rise in U.S. tariffs, according to analysts at Barclays. In a note to clients on Wednesday, the brokerage said the effect is appearing in negative Wall Street revisions and expectations for "margin degradation."
Johnson & Johnson has slashed on Wednesday its estimate for the impact of tariffs in 2025, which it now expects to be around $200 million. The company’s stock is climbing in morning trading, boosted by better-than-expected second-quarter results and raised outlook,